Analysts/Institutional Investor Meet/Con. Call Updates

GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTINFRA/CS/SE/2026-27 November 5, 2026 The Department of Corporate Services National Stock Exchange of India Limited BSE Limited, Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Dalal Street Bandra-Kurla Complex, Bandra (E), Mumbai – 400001 Mumbai - 400051 Scrip Code: 533761 Scrip Symbol: GPTINFRA ISIN: INE390G01014 Dear Sir/Madam Sub: Audio recording of conference call for discussion on Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2026: In compliance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company Participated in a conference call with Investors today i.e. Thursday, November 5, 2026 at 11:00 AM (IST) to discuss the financial performance of the Company on the Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2026. No unpublished price sensitive information was shared / discussed in the meeting. The link for Audio recording: https://gpt-infra.s3.ap-south-1.amazonaws.com/earning-calls/05_11_2026_10049115.mp3 The same has been uploaded at the website of the Company. Kindly take the aforesaid information on record and oblige. Thanking You, Yours Sincerely, For GPT Infraprojects Limited Sonam Lakhotia Company Secretary & Compliance Officer Mem No.: A41358